City, not to nitpick, however ...

”Breakthrough Therapy designation is intended to expedite the development and 'review' of drugs for serious or life-threatening conditions. The criteria for Breakthrough Therapy designation require preliminary clinical evidence that demonstrates the drug may have impact on at least one clinically significant endpoint over available therapy.”